These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9163730)

  • 61. A novel missense mutation of the TYR gene in a pedigree with oculocutaneous albinism type 1 from China.
    Lin YY; Wei AH; Zhou ZY; Zhu W; He X; Lian S
    Chin Med J (Engl); 2011 Oct; 124(20):3358-61. PubMed ID: 22088535
    [TBL] [Abstract][Full Text] [Related]  

  • 62. DNA-based carrier detection and prenatal diagnosis of tyrosinase-negative oculocutaneous albinism (OCA1A).
    Falik-Borenstein TC; Holmes SA; Borochowitz Z; Levin A; Rosenmann A; Spritz RA
    Prenat Diagn; 1995 Apr; 15(4):345-9. PubMed ID: 7617575
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Novel and recurrent mutations in the tyrosinase gene and the P gene in the German albino population.
    Passmore LA; Kaesmann-Kellner B; Weber BH
    Hum Genet; 1999 Sep; 105(3):200-10. PubMed ID: 10987646
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism.
    Lee ST; Nicholls RD; Bundey S; Laxova R; Musarella M; Spritz RA
    N Engl J Med; 1994 Feb; 330(8):529-34. PubMed ID: 8302318
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cloning and sequence analysis of the tyrosinase gene from a patient with tyrosinase-positive oculocutaneous albinism.
    Matsunaga J; Takeda A; Tomita Y; Hara M; Shibahara S; Tagami H
    J Dermatol Sci; 1992 May; 3(3):181-5. PubMed ID: 1498098
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Spectrum of candidate gene mutations associated with Indian familial oculocutaneous and ocular albinism.
    Renugadevi K; Sil AK; Perumalsamy V; Sundaresan P
    Mol Vis; 2010 Aug; 16():1514-24. PubMed ID: 20806075
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Detection of point mutations in human tyrosinase gene by improved allele-specific amplification.
    Matsunaga J; Tomita Y; Tagami H
    Exp Dermatol; 1995 Dec; 4(6):377-81. PubMed ID: 8608346
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Oculocutaneous albinism (OCA) in Colombia: first molecular screening of the TYR and OCA2 genes in South America.
    Urtatiz O; Sanabria D; Lattig MC
    J Dermatol Sci; 2014 Dec; 76(3):260-2. PubMed ID: 25455140
    [No Abstract]   [Full Text] [Related]  

  • 69. Comprehensive analysis of the molecular basis of oculocutaneous albinism in Indian patients lacking a mutation in the tyrosinase gene.
    Sengupta M; Mondal M; Jaiswal P; Sinha S; Chaki M; Samanta S; Ray K
    Br J Dermatol; 2010 Sep; 163(3):487-94. PubMed ID: 20426782
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The molecular basis of type I (tyrosinase-deficient) human oculocutaneous albinism.
    Giebel LB; Spritz RA
    Pigment Cell Res; 1992; Suppl 2():101-6. PubMed ID: 1409411
    [No Abstract]   [Full Text] [Related]  

  • 71. African origin of an intragenic deletion of the human P gene in tyrosinase positive oculocutaneous albinism.
    Durham-Pierre D; Gardner JM; Nakatsu Y; King RA; Francke U; Ching A; Aquaron R; del Marmol V; Brilliant MH
    Nat Genet; 1994 Jun; 7(2):176-9. PubMed ID: 7920637
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [An overview of oculocutaneous albinism: TYR gene mutations in five Colombian individuals].
    Sanabria D; Groot H; Guzmán J; Lattig MC
    Biomedica; 2012 Jun; 32(2):269-76. PubMed ID: 23242301
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A frequent tyrosinase gene mutation associated with type I-A (tyrosinase-negative) oculocutaneous albinism in Puerto Rico.
    Oetting WS; Witkop CJ; Brown SA; Colomer R; Fryer JP; Bloom KE; King RA
    Am J Hum Genet; 1993 Jan; 52(1):17-23. PubMed ID: 8434585
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification of a missense mutation in the tyrosinase gene in a Chinese family with oculocutaneous albinism type 1.
    Lu Q; Yuan L; Xu H; Huang X; Yang Z; Yi J; Ni B; Chen Y; Deng H
    Mol Med Rep; 2017 Mar; 15(3):1426-1430. PubMed ID: 28112372
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of a functionally significant tri-allelic genotype in the Tyrosinase gene (TYR) causing hypomorphic oculocutaneous albinism (OCA1B).
    Norman CS; O'Gorman L; Gibson J; Pengelly RJ; Baralle D; Ratnayaka JA; Griffiths H; Rose-Zerilli M; Ranger M; Bunyan D; Lee H; Page R; Newall T; Shawkat F; Mattocks C; Ward D; Ennis S; Self JE
    Sci Rep; 2017 Jun; 7(1):4415. PubMed ID: 28667292
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel.
    Gershoni-Baruch R; Rosenmann A; Droetto S; Holmes S; Tripathi RK; Spritz RA
    Am J Hum Genet; 1994 Apr; 54(4):586-94. PubMed ID: 8128955
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular analysis of Korean patients with oculocutaneous albinism.
    Park SH; Chae H; Kim Y; Kim M
    Jpn J Ophthalmol; 2012 Jan; 56(1):98-103. PubMed ID: 22042571
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Genetics of oculocutaneous albinism].
    Zühlke C; Stell A; Käsmann-Kellner B
    Ophthalmologe; 2007 Aug; 104(8):674-80. PubMed ID: 17646993
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The R402Q tyrosinase variant does not cause autosomal recessive ocular albinism.
    Oetting WS; Pietsch J; Brott MJ; Savage S; Fryer JP; Summers CG; King RA
    Am J Med Genet A; 2009 Mar; 149A(3):466-9. PubMed ID: 19208379
    [TBL] [Abstract][Full Text] [Related]  

  • 80. TYR mutation in a Chinese population with oculocutaneous albinism: Molecular characteristics and ophthalmic manifestations.
    Chen C; Li J; Wang B; Wang Y; Yu X
    Exp Eye Res; 2024 Feb; 239():109761. PubMed ID: 38145795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.